Cardiac Science Corporation Appoints Ronald A. Andrews, Jr. to Board of Directors
Posted on 11/6/2009 8:04:00 PM in #Stocks | 0 comments comments
Cardiac Science Corporation (NASDAQ: CSCX) has appointed Ronald A. Andrews, Jr. to their Board of Directors. He will replace Jue-Hsien Chern, Ph.D., who stepped down from his seat on November 5th. The total number of directors will stay at 6. Andrews is currently the Vice Chairman and CEO of Clarient, Inc. (NASDAQ: CLRT). Andrews received a bachelor's degree in biology and chemistry from Wofford College. He has also participated in executive development programs at Roche and Abbott Labs. Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks. About Cardiac Science: Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, vital signs monitors, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. Follow us on Twitter: http://www.twitter.com/pennystockspro Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website. About Us Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below. Please click here to read the full disclaimer. staff@pennystockprofessor.com
www.pennystockprofessor.com
|